Period A (2000-2003) n = 41 | Period B (2004-2009) n = 115 | pvalue (comparing MRSA infection in the two periods) | |||
---|---|---|---|---|---|
Complications | MSSA (n = 31) | MRSA (n = 10) | MSSA (n = 51) | MRSA (n = 64) | |
Septic shock | 0 (0%) | 1 (2.4%) | 4 (3.5%) | 13 (11.3%) | 0.115 |
Concomitant soft tissue/skin infection | 4 (9.8%) | 6 (14.6%) | 5 (4.3%) | 13 (11.3%) | 0.584 |
Pneumonia | 6 (14.6%) | 1 (2.4%) | 7 (6.1%) | 31 (27.0%) | 0.0005 |
Necrotizing enterocolitis | 1 (2.4%) | 4 (9.8%) | 3 (2.6%) | 5 (4.3%) | 0.2435 |
Mortality | 4 (9.8%) | 0 (0%) | 6 (5.2%) | 18 (15.7%) | 0.0038 |
Length of hospitalization (mean number of days) | 87.4 ± 40.6 | 80.6 ± 42.4 | 55.7 ± 30.2 | 53.6 ± 36.6 | 0.0371 |